FG

Fabrice Le Gall

AG Affimed Gmbh: 3 patents #9 of 24Top 40%
AP Astellas Pharma: 2 patents #350 of 954Top 40%
BA Biontech Ag: 2 patents #11 of 66Top 20%
GG Ganymed Pharmaceuticals Gmbh: 2 patents #25 of 49Top 55%
BS Biontech Se: 1 patents #72 of 136Top 55%
📍 Edingen-Neckarhausen, DE: #15 of 78 inventorsTop 20%
Overall (All Time): #617,651 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
11787862 Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2 and CD3 for treatment of Claudin expressing cancer diseases Ugur Sahin, Christiane Stadler, Leyla Fischer, Arne Jendretzki, Ozlem Tureci +1 more 2023-10-17
11541127 Drug conjugates comprising antibodies against claudin 18.2 Ugur Sahin, Ozlem Tureci, Korden Walter, Maria Kreuzberg, Rita Mitnacht-Kraus +1 more 2023-01-03
10717780 Agents for treatment of claudin expressing cancer diseases Ugur Sahin, Ozlem Tureci, Christiane Stadler, Julia Holland, Hayat Bähr-Mahmud +4 more 2020-07-21
10093736 Agents for treatment of claudin expressing cancer diseases Ugur Sahin, Ozlem Tureci, Christiane Stadler, Julia Holland, Hayat Bähr-Mahmud +4 more 2018-10-09
9701750 Anti-CD16 binding molecules Karin Hoffmann, Sergey Kipriyanov, Stefan Knackmuss, Melvyn Little, Uwe Reusch 2017-07-11
9226962 Human CD3-specific antibody with immunosuppressive properties Sergey Kipriyanov, Melvin Little, Uwe Reusch 2016-01-05
9035026 Anti-CD16 binding molecules Karin Hoffmann, Sergey Kipriyanov, Stefan Knackmuss, Melvyn Little, Uwe Reusch 2015-05-19
7901677 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types Melvyn Little, Stefan Knackmuss, Uwe Reusch, Sergey Kipriyanov, Vera Mick +2 more 2011-03-08